Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial.
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint,... Read more.
Caring for the Imminently Dying Patient: When resuscitation shifts to comfort in the Emergency Department
As Emergency Physicians, we are all experts in saving lives, yet we are often least prepared for the moment when a patient is imminently dying. The hardest decision... Read more.
